Natural Killer T cells Balancing the Regulation of Tumor Immunity /
Natural killer T (NKT) cells are CD1d-restricted T cells that respond to lipid, not protein, antigens presented by CD1d, which is a non-classical MHC class I-like molecule. This relatively small but pivotal T cell population bridges the gap between innate and adaptive immunity by rapidly produce la...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
New York, NY :
Springer New York,
2012.
|
Έκδοση: | 1. |
Σειρά: | Cancer Drug Discovery and Development
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Preface.- Introduction: Mechanisms of NKT cell-mediated adjuvant activity and function of iPS-derived NKT cells
- Structure and Recognition of Antigens for Invariant NKT Cells
- Invariant NKT cell-based vaccine strategies
- Immune regulation of tumor immunity by NKT cells
- The Regulation of CD1d+ and CD1d- tumors by NKT Cells
- DC-based immunotherapy targeting NKT cells
- Therapeutic Approaches Utilising NKT Cells
- NKT Cells of Cancer Patients & How Models can Inform Therapeutic Plans
- Understanding the role of Natural Killer T (NKT) cells in hematologic malignancies: progress and challenges
- Clinical trials with α-galactosylceramide (KRN7000) in advanced cancer
- Clinical trials of invariant Natural Killer T cell-based immunotherapy for cancer
- Index. .